Godo Shigeo, Takagi Hidenobu, Komaru Kohei, Takahashi Jun, Yasuda Satoshi
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, 980-8574 Sendai, Japan.
Department of Diagnostic Radiology, Tohoku University Hospital, Sendai, Japan.
Eur Heart J Case Rep. 2024 May 15;8(5):ytae247. doi: 10.1093/ehjcr/ytae247. eCollection 2024 May.
Hypereosinophilic syndrome (HES) is characterized by moderate to severe eosinophilia, exclusion of neoplastic or secondary origins of eosinophilia, and systemic involvement with end-organ damage. Coronary arteries can be affected to cause vasospastic angina (VSA); however, the association of the two diseases is not well recognized.
A 55-year-old woman who had a history of multiple allergic disease such as bronchial asthma and chronic sinusitis with nasal polyps was hospitalized due to attacks of chest pain at rest. During a spontaneous attack of chest pain, ECG revealed ST-segment elevation in the inferior leads and emergency coronary angiography showed focal spasms of the right and left anterior descending coronary arteries, both of which were relieved after intracoronary administration of nitroglycerine. She was diagnosed with VSA according to the Japanese Circulation Society guidelines. Despite conventional vasodilator therapies, her resting angina remained refractory. Laboratory findings were notable for moderate eosinophilia. A comprehensive evaluation to uncover the underlying cause of refractory VSA led to the diagnosis of HES, concomitant with eosinophilic pneumonia and eosinophilic chronic rhinosinusitis. Pericoronary inflammation by fat attenuation index (FAI) was increased in the proximal segment of the right coronary artery. Treatment was initiated with oral prednisolone at a starting dose of 30 mg/day. The response to treatment was rapid, with her symptoms disappearing and a regression of eosinophilia observed the following day.
Hypereosinophilic syndrome manifests with refractory VSA, and eosinophil-suppressing corticosteroid therapy proves effective in improving both conditions along with reduction of the pericoronary inflammation by FAI.
高嗜酸性粒细胞综合征(HES)的特征为中度至重度嗜酸性粒细胞增多、排除嗜酸性粒细胞增多的肿瘤性或继发性病因以及伴有终末器官损害的全身受累。冠状动脉可受影响导致血管痉挛性心绞痛(VSA);然而,这两种疾病的关联尚未得到充分认识。
一名55岁女性,有支气管哮喘和慢性鼻窦炎伴鼻息肉等多种过敏性疾病史,因静息时胸痛发作入院。在胸痛自发发作期间,心电图显示下壁导联ST段抬高,急诊冠状动脉造影显示右冠状动脉和左前降支冠状动脉局灶性痉挛,冠状动脉内注射硝酸甘油后痉挛均缓解。根据日本循环学会指南,她被诊断为VSA。尽管采用了传统的血管扩张剂治疗,她的静息性心绞痛仍难以控制。实验室检查结果显示中度嗜酸性粒细胞增多。为查明难治性VSA的潜在病因进行的全面评估导致诊断为HES,同时伴有嗜酸性粒细胞性肺炎和嗜酸性粒细胞性慢性鼻窦炎。右冠状动脉近端脂肪衰减指数(FAI)显示的冠状动脉周围炎症增加。开始口服泼尼松龙治疗,起始剂量为30mg/天。治疗反应迅速,第二天她的症状消失,嗜酸性粒细胞增多有所消退。
高嗜酸性粒细胞综合征表现为难治性VSA,抑制嗜酸性粒细胞的皮质类固醇治疗被证明对改善这两种情况以及通过FAI减轻冠状动脉周围炎症有效。